Albemarle Corp (ALB) Stock Forecast Oct. 14, 2026
Analysis updated on Oct. 14, 2026 (UTC) · Alpha · vs marketSwitch to Total · NYSE
Albemarle Corp (ALB) stock forecast summary
Our AI ranks Albemarle Corp outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
Albemarle Corp is a large-cap company with a market capitalization of $11.52B. It ranks number 2 by market capitalization among the 9 Plastic Materials, Synth Resins & Nonvulcan Elastomers issuers in our coverage with a current forecast.
A per-ticker accuracy statistic for ALB is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +1.3%, buy ≥ +0.5%, sell < -0.6%, strong sell < -1.7% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-14 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, ALB included.
Follow ALB freeALB price chart and AI forecast
How ALB ranks among 4004 stocks
90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Albemarle Corp (ALB) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Plastic Materials, Synth Resins & Nonvulcan Elastomers peers listed below that report each metric.
Reported net income does not reconcile with earnings per share and the share count, so net-income-based ratios are withheld.
Valuation & Market
| Metric | ALB | Rank |
|---|---|---|
| Market Cap | $11.52B | 2/9 |
| P/B Ratio | 1.12x | 6/8 |
| Dividend Yield | 3.43% | 3/6 |
| EPS | $0.26 | – |
| Book Value/Share | $87.07 | – |
| Revenue/Share | $50.06 | – |
| FCF/Share | $11.38 | – |
Profitability & Margins
| Metric | ALB | Rank |
|---|---|---|
| ROIC | 1.8% | 4/8 |
| Gross Margin | 23.8% | 4/8 |
| Operating Margin | 4.3% | 4/8 |
| EBT Margin | 3.6% | 5/10 |
| Tax Rate | 112.4% | – |
The effective tax rate is outside the normal band, which points to a large non-recurring tax item in the trailing twelve months; headline net income, net margin and P/E are affected by it.
Financial Health
| Metric | ALB | Rank |
|---|---|---|
| Current Ratio | 2.09x | 5/10 |
| Quick Ratio | 1.35x | 5/10 |
| D/E Ratio | 0.52x | 7/8 |
| Financial Leverage | 1.55x | 7/8 |
| Working Capital | $2.05B | 2/10 |
Cash Flow
| Metric | ALB | Rank |
|---|---|---|
| Operating Cash Flow | $1.80B | 1/9 |
| Free Cash Flow | $1.34B | 1/9 |
| Capital Spending | -$458M | 9/9 |
| OCF Growth YoY | 131.0% | 1/7 |
| FCF/Sales | 22.7% | 3/9 |
| CapEx/Sales | 7.8% | 3/9 |
Operational Efficiency
| Metric | ALB | Rank |
|---|---|---|
| Asset Turnover | 0.37x | 6/9 |
| Receivables Turnover | 9.8x | 1/7 |
| Inventory Turnover | 3.2x | 7/8 |
| Fixed Assets Turnover | 0.7x | 7/9 |
| Days Sales Outstanding | 37 days | 7/7 |
| Days Inventory | 112 days | 2/8 |
Income Statement
| Metric | ALB | Rank |
|---|---|---|
| Total Revenue | $5.91B | 2/9 |
| Operating Income | $252M | 3/8 |
| R&D Expense | $38M | 3/6 |
| SG&A Expense | $558M | 4/9 |
| Cost of Goods Sold | $4.50B | 2/8 |
Dividend & Shareholder Information
| Metric | ALB | Rank |
|---|---|---|
| Dividends Per Share | $3.35 | – |
| Payout Ratio | 1288.5% | 1/6 |
| Shares Outstanding | 118M | – |
Balance Sheet Highlights (USD millions)
| Total Current Assets | $3.94B | 24.8% of assets |
| Cash & Short-term Investments | $1.63B | 10.3% of assets |
| Accounts Receivable | $604M | 3.8% of assets |
| Inventory | $1.38B | 8.7% of assets |
| Total Liabilities | $5.37B | 33.8% of assets |
ALB quarterly financials and insider trading
Albemarle Corp (ALB) industry peers
Companies classified under the same SEC industry code as Albemarle Corp (Plastic Materials, Synth Resins & Nonvulcan Elastomers): 10 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Alpha) | Market Cap |
|---|---|---|
| ALB Albemarle Corp | ▼ | $11.52B |
| DD Dupont De Nemours, Inc. | ▼ | $17.49B |
| EMN Eastman Chemical Co | ▲ | $7.21B |
| HXL Hexcel Corp /De/ | ▼ | $6.51B |
| AVNT Avient Corp | ▼ | $3.63B |
| ROG Rogers Corp | ▶ | $2.61B |
| PCT Purecycle Technologies, Inc. | ▲ | $691M |
| ASIX Advansix Inc. | ▼ | $449M |
| TSEOQ Trinseo Plc | ▶ | $150K |
| HGYN Hong Yuan Holding Group | ▼ | N/A |
Where ALB sits on the market map
Albemarle Corp (ALB) stock news
Loading...
Albemarle Corp (ALB) stock forecast FAQ
What is the Albemarle Corp (ALB) stock forecast?
Our AI ranks Albemarle Corp outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
How accurate are Albemarle Corp stock predictions?
A per-ticker accuracy statistic for ALB is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Albemarle Corp forecasts updated?
Albemarle Corp forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 14, 2026.
Which companies are Albemarle Corp's industry peers?
10 issuers in our coverage, ALB included, share the SEC industry code Plastic Materials, Synth Resins & Nonvulcan Elastomers. The largest are: Dupont De Nemours, Inc. (DD), Eastman Chemical Co (EMN), Hexcel Corp /De/ (HXL), Avient Corp (AVNT), Rogers Corp (ROG), Purecycle Technologies, Inc. (PCT).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.